Home »
Technology »
Inhalation Technology

Inhalation Technology

SkyePharma offers its partners a range of leading technologies for dry powder inhalers (DPIs) and HFA propelled (CFC-free) metered dose inhalers (MDIs) and extensive know how and experience in development of inhalation products.

Our most recent development has been flutiform®, a fixed-dose combination of the fast-onset long-acting beta-agonist (formoterol fumarate) and the commonly prescribed corticosteroid (fluticasone propionate) in a metered dose inhaler using an environmentally-friendly, CFC free aerosol propellant.

SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom